# Taizhou leiling Baiao Biotechnology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/taizhou-leiling-baiao-biotechnology

- Industry: Biotechnology
- Headquarters: Taizhou, China
- Total disclosed funding: $7.8M
- Latest round: Series A (Nov 6, 2021)
- Investors on record: 2

## About

Established in 2019 and based in Taizhou, China, Taizhou leiling Baiao Biotechnology operates as a biotechnology extension service provider that focuses on molecular diagnostic system. The core research team of the company has more than 80% of its all employees.

The company provides molecular diagnosis and physical killing products for animal husbandry and veterinary industry. The company focuses on accurate diagnosis and non-toxic treatment. The product of the company includes new drugs, vaccines, diagnostic reagents and insecticidal sterilization.

The company will increase investment in researching and developing technology, expand product scale and market, construct workshop and declare product.

## Funding rounds

- Series A, Nov 6, 2021, $7.8M — Shanghai Lingyue Capital, Taizhou China Medical City New Drug Fund Management

## Investors

- Shanghai Lingyue Capital (https://capitalatlas.ai/funds/shanghai-lingyue-capital) — Series A
- Taizhou China Medical City New Drug Fund Management (https://capitalatlas.ai/funds/taizhou-china-medical-city-new-drug-fund-management) — Series A